Source:http://linkedlifedata.com/resource/pubmed/id/10637555
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
1
|
| pubmed:dateCreated |
2000-2-2
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Jan
|
| pubmed:issn |
0167-5699
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
21
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
24-8
|
| pubmed:dateRevised |
2005-11-16
|
| pubmed:meshHeading | |
| pubmed:year |
2000
|
| pubmed:articleTitle |
Interferon beta in multiple sclerosis: is IL-12 suppression the key?
|
| pubmed:affiliation |
Depts of Medicine and Molecular Microbiology and Immunology, Johns Hopkins University, Baltimore, MD 21205, USA. ckarp@jhmi.edu
|
| pubmed:publicationType |
Journal Article,
Review
|